UnitedHealth Group (UNH) cash flow statement

Managed Health Care · NYSE · Health Care

$389.68 -5.42% Close Nov 17, 2026 Live

TrendArc score 51 of 100 · Health 6.1 · Momentum 5.5 · Moat 6.9 · scored Nov 17, 2026 · How the score works

Free cash flow, fiscal year to December 31, 2025

$16.1 billion

down 22.4% from the year before

UnitedHealth Group generated $16.1 billion of free cash flow in the fiscal year to December 2025: $19.7 billion of cash from operations less $3.6 billion of capital spending. That was 3.6% of revenue, against 5.2% the year before. Over the last four quarters, to September 30, 2026, it was $22.8 billion.

What stands out

  • Free cash flow exceeded net income in each of the last five fiscal years: $105.8 billion against $86.2 billion in total.
  • Net share repurchases of $4.7 billion and dividends of $7.9 billion came to 79% of free cash flow in the fiscal year to December 2025.
  • Cash dividends paid rose in each of the last five fiscal years, from $4.6 billion to $7.9 billion in total.

Each sentence is written by a fixed rule from the figures on this page.

Free cash flow and net income, the last 10 fiscal years

$10.0B$20.0B$30.0B2016201720182019202020212022202320242025$8.09BFree cash flow $16.1BNet income $12.1B$10.0B$20.0B$30.0B20172019202120232025Free cash flow $16.1BNet income $12.1B

Fiscal years, each labelled by the calendar year it ended in. Every figure is in the statement below.

Where the cash wentFiscal year to December 31, 2025

  1. Cash from operations 19.7
  2. Capital spending -3.6
  3. Free cash flow 16.1
  4. Businesses bought and sold, net -2.3
  5. Investments bought and sold, net -2.5
  6. Net share repurchases -4.7
  7. Dividends -7.9
  8. Debt and other 0.3
  9. Net change in cash -0.9

In billions of US dollars. Outflows are grey, not red: a buyback is not a loss. "Debt and other" closes the gap to the reported change in cash. Buying marketable securities moves cash into short-term investments; the balance sheet shows both.

Cash flow statement, the last 10 fiscal years

In billions of US dollars. Each column is a fiscal year, named by the month it ended; the first column adds up the last four quarters. Cash paid out is a negative number.
Fiscal year toLast 4 quarters
to Sep 2026
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating activities
Net income12.114.422.420.117.315.413.812.010.67.0
Depreciation and amortisation4.44.14.03.43.12.92.72.42.22.1
Stock-based pay1.01.01.01.10.90.80.70.70.60.60.5
Working capital and other items2.34.71.71.81.23.21.20.70.20.2
Cash from operations26.219.724.229.126.222.322.218.515.713.69.8
Investing activities
Capital spending-3.4-3.6-3.5-3.4-2.8-2.5-2.1-2.1-2.1-2.0-1.7
Businesses bought and sold, net-2.3-15.9-9.5-18.0-4.8-6.9-8.3-6.0-2.1-1.8
Investments bought and sold, net-2.5-1.0-2.8-6.8-1.8-2.8-2.5-4.1-4.3-5.9
Other investing-0.3-0.10.1-0.8-1.3-0.70.2-0.2-0.10.0
Cash from investing-8.7-20.5-15.6-28.5-10.4-12.5-12.7-12.4-8.6-9.4
Financing activities
Debt issued or repaid, net0.714.74.312.52.52.64.04.1-2.61.0
Shares issued less bought back-4.4-4.7-7.2-6.6-5.7-3.6-2.8-4.5-3.7-0.8-0.9
Dividends paid-8.2-7.9-7.5-6.8-6.0-5.3-4.6-3.9-3.3-2.8-2.3
Other financing0.3-3.5-2.43.4-1.01.2-1.2-1.52.81.1
Cash from financing-11.6-3.5-11.54.2-7.5-3.6-5.6-4.4-3.4-1.0
Net change in cash-0.9-0.12.12.04.55.90.1-1.11.6-0.5
Free cash flow
Free cash flow22.816.120.725.723.419.920.116.413.711.68.1
Free cash flow margin5.1%3.6%5.2%6.9%7.2%6.9%7.8%6.8%6.0%5.8%4.4%
Free cash flow per share$17.65$22.29$27.38$24.64$20.80$20.94$16.97$13.89$11.75$8.36

Shares issued less bought back is the cash from shares sold less the cash paid for shares bought back (negative when more was bought back), and includes tax withheld when employees' shares vest. Working capital and other items is cash from operations less net income, depreciation and amortisation, and stock-based pay (calculated by TrendArc). Company filings as standardised by Tiingo; calculations by TrendArc. Rebuilt nightly.

UnitedHealth Group against its peers

CompanyFiscal year toFree cash flowFree cash flow margin
Veeva SystemsVEEV Jan 2026$1.39B43.4%
HCA HealthcareHCA Dec 2025$7.69B10.2%
UnitedHealth GroupUNH Dec 2025$16.1B3.6%
CignaCI Dec 2025$8.39B3.1%
CVS HealthCVS Dec 2025$7.81B1.9%
Cardinal HealthCAH Jun 2026$4.56B1.8%
Elevance HealthELV Dec 2025$3.17B1.6%
HumanaHUM Dec 2025$398M0.3%
Peer median1.9%

Each company's newest fiscal year; some end in other months. The peers are the stock card's peer group.

Next

Follow UnitedHealth Group with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes UnitedHealth Group from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.